Skip to main content
. 2024 Jan 2;14:114. doi: 10.1038/s41598-023-50277-z

Table 4.

The association between the demographic, clinical and laboratory variables and the MTHFR A1298C polymorphisms in stroke patients.

AC + CC
n = 89
AA
n = 11
Test (P) P
SBP (mmHg) 130.0 (100.0–190.0) 130.0 (90.0–160.0) T = 0.302 0.764
DBP (mmHg) 80.0 (50.0–100.0) 80.0 (60.0–100.0) T = 0.594 0.554
Triglyceride (mg/dl) 118.0 (26.0–887.0) 131.0 (62.0–578.0) U = 474.5 0.869
Total cholesterol (mg/dl) 173.0 (80.0–302.0) 145.0 (72.0–284.0) T = 1.290 0.2
HDL-C (mg/dl) 35.6 (25.0–60.0) 35.4 (28.0–39.0) T = 1.078 0.284
LDL-C (mg/dl) 110.8 (12.40–222.40) 90.2 (31.0–133.0) U = 638.5 0.101
VLDL-C (mg/dl) 23.6 (5.20–177.40) 26.2 (12.40–115.60) U = 474.5 0.869
Gender
 Male 52 (58.4%) 8 (72.7%) X2 = 0.834 0.518
 Female 37 (41.6%) 3 (27.3%)
Smoking status
 Absent 49 (55.1%) 5 (45.5%) X2 = 0.363 0.547
 Present 40 (44.9%) 6 (54.5%)

OR odds ratio, CI confidence interval; P < 0.05 significant, T student t test, U Mann Whitney test, X2 chi square test.